NICE have issued guidance concerning the management of erectile dysfunction in patients with type 2 diabetes:
review the issue of erectile dysfunction with men annually
provide assessment and education for men with erectile dysfunction to address contributory factors and treatment options
pharmacological management
offer a phosphodiesterase-5 inhibitor (choosing the drug with the lowest acquisition cost), in the absence of contraindications, if erectile dysfunction is a problem
if phosphodiesterase-5 inhibitors have been unsuccessful
following discussion, refer to a service offering other medical, surgical, or psychological management of erectile dysfunction
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.